Many people taking Wegovy report feeling colder than usual, particularly in their hands and feet
Frag 176-191 is thought to mimic GHs lipolytic (fat-breaking) potential while seemingly not affecting carbohydrate metabolism, insulin-like growth factor-1 (IGF-1) synthesis, or cellular proliferation
When considering fatigue as a side effect, its useful to understand how retatrutide compares with tirzepatide and semaglutide
Log in ABC (Akkermansia BPC Complex) InfiniWell 60 capsules $N/A (MSRP) Already have an account
When to call your provider Within 3-5 days: No bowel movement for 5+ days despite using Miralax or other osmotic laxative Severe abdominal pain or distension Inability to pass gas Vomiting, especially if it tastes or smells fecal Within 1-2 weeks: Constipation not improving after 2 weeks of consistent dietary changes plus Miralax Blood in stool (bright red or dark/tarry) Severe pain during bowel movements Unintended weight loss beyond expected from the medication At your next scheduled visit: Mild persistent constipation that's manageable but bothersome Questions about whether to escalate dose given current constipation Interest in prescription motility agents The threshold for calling is lower if you have a history of bowel obstruction, diverticulitis, inflammatory bowel disease, or prior abdominal surgery
Survey data demonstrate people taking GLP-1RAs semaglutide and tirzepatide report reduced sedative and stimulative effects of alcohol 18
